- Home
- MRT vs OABI Comparison
MRT vs OABI Comparison
Compare MRT & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRT
- OABI
- Stock Information
- Founded
- MRT 2018
- OABI 2012
- Country
- MRT Turkey
- OABI United States
- Employees
- MRT N/A
- OABI N/A
- Industry
- MRT Rental/Leasing Companies
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- MRT Consumer Discretionary
- OABI Health Care
- Exchange
- MRT Nasdaq
- OABI Nasdaq
- Market Cap
- MRT 228.0M
- OABI 185.9M
- IPO Year
- MRT N/A
- OABI N/A
- Fundamental
- Price
- MRT $2.94
- OABI $1.41
- Analyst Decision
- MRT Strong Buy
- OABI Strong Buy
- Analyst Count
- MRT 2
- OABI 3
- Target Price
- MRT $6.00
- OABI $7.00
- AVG Volume (30 Days)
- MRT 79.7K
- OABI 935.9K
- Earning Date
- MRT 08-08-2018
- OABI 05-08-2025
- Dividend Yield
- MRT N/A
- OABI N/A
- EPS Growth
- MRT N/A
- OABI N/A
- EPS
- MRT N/A
- OABI N/A
- Revenue
- MRT $18,659,655.00
- OABI $26,744,000.00
- Revenue This Year
- MRT $83.29
- OABI N/A
- Revenue Next Year
- MRT $106.66
- OABI $40.06
- P/E Ratio
- MRT N/A
- OABI N/A
- Revenue Growth
- MRT N/A
- OABI 27.07
- 52 Week Low
- MRT $1.32
- OABI $1.22
- 52 Week High
- MRT $3.89
- OABI $4.96
- Technical
- Relative Strength Index (RSI)
- MRT 44.48
- OABI 39.84
- Support Level
- MRT $2.92
- OABI $1.22
- Resistance Level
- MRT $3.02
- OABI $1.41
- Average True Range (ATR)
- MRT 0.19
- OABI 0.09
- MACD
- MRT -0.03
- OABI 0.01
- Stochastic Oscillator
- MRT 15.29
- OABI 46.34
About MRT Marti Technologies Inc.
Marti Technologies Inc is a mobility app, offering multiple transportation services to its riders. Marti operates a ride-hailing service that matches riders with car, motorcycle, and taxi drivers, and operates a large fleet of rental e-mopeds, e-bikes, and e-scooters. All of Marti's offerings are serviced by proprietary software systems and IoT infrastructure.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.